Search Results - "Tuccia, F"

State of the art of the funerary archaeoentomological investigations in Italy by Tuccia, F., Giordani, G., Vanin, S.

“…Archaeoentomology is a branch of environmental archaeology focusing on insects and other arthropods contributing, with other disciplines, to reconstruct a more…”
Get full text

Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis by Tarantini, L., Gori, S., Faggiano, P., Pulignano, G., Simoncini, E., Tuccia, F., Ceccherini, R., Bovelli, D., Lestuzzi, C., Cioffi, G.

“…Adjuvant Trastuzumab with chemotherapy is the gold standard for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (HER2+ EBC). Older…”
Get full text

First record of Physyphora alceae (Preyssler, 1791) (Diptera, Ulidiidae) from a forensic case in Northern Italy: description of immature stages, DNA barcoding and phylogenetic analysis by Tuccia, F., Giordani, G., Cattaneo, C., Mazzarelli, D., Vanin, S.

“…In forensic entomology the estimation of the minimum postmortem interval and any other evaluation depend on the accuracy of the species identification. Despite…”
Get full text

Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification by Saracchini, S, Foltran, L, Tuccia, F, Bassini, A, Sulfaro, S, Micheli, E, Del Conte, A, Bertola, M, Gion, M, Lorenzon, M, Tumolo, S

“…Abstract Purpose of the study Trastuzumab combined with sequential chemotherapy with taxanes and anthracyclines as primary systemic therapy achieved high rates…”
Get full text

Environmental necrophagous fauna selection in a funerary hypogeal context: The putridarium of the Franciscan monastery of Azzio (northern Italy) by Pradelli, J., Rossetti, C., Tuccia, F., Giordani, G., Licata, M., Birkhoff, J.M., Verzeletti, A., Vanin, S.

Get full text

Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis by Tarantini, L, Gori, S, Faggiano, P, Pulignano, G, Simoncini, E, Tuccia, F, Ceccherini, R, Bovelli, D, Lestuzzi, C, Cioffi, G

“…Adjuvant Trastuzumab with chemotherapy is the gold standard for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (HER2+ EBC). Older…”
Get full text